1. Academic Validation
  2. Molecular characterization of Complement Factor I deficiency in two Spanish families

Molecular characterization of Complement Factor I deficiency in two Spanish families

  • Mol Immunol. 2008 May;45(10):2764-71. doi: 10.1016/j.molimm.2008.02.008.
Isabel María Ponce-Castro 1 Carolina González-Rubio Eva María Delgado-Cerviño Cynthia Abarrategui-Garrido Gumersindo Fontán Pilar Sánchez-Corral Margarita López-Trascasa
Affiliations

Affiliation

  • 1 Unidad de Inmunología, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid, Spain.
Abstract

Complement Factor I (CFI) is a regulator of the classical and alternative pathways. CFI has enzymatic activity and is able to cleave C3b and C4b. Homozygous Factor I deficiency is associated with infectious and/or autoimmune diseases. Here we describe the biochemical and genetic characterization in two Spanish families with complete Factor I deficiency. In Family 1, the propositus suffered from several episodes of meningitis for more than a year. Biochemical complement studies showed undetectable Factor I levels in the propositus and in her sister, while their parents and a brother had partial Factor I deficiency and were healthy. In Family 2, three out of five children were homozygous for Factor I deficiency, two of whom suffered from meningitis and the third one from several infections. The parents and the Other two siblings were healthy and heterozygous for Factor I deficiency. Molecular studies showed that the two families had different mutations at exon 5 of the Factor I gene, which codifies for module LDLr1. One mutation corresponds to a 772G>A change at the donor splice site that was originally found in a family from Northern England. The second is a new missense mutation 739T>G, that generates a Cys to Gly change.

Figures